Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMG0703 in Periodontitis
NCT04446533Phase 3Unknown
- Sponsor
- University of Milan
- Start
- Jun 2020
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in periodontitis (3 arms), sponsored by University of Milan. Primary endpoints: Change in Bleeding index at 30 days and Change in Plaque index at 30 days. Status: unknown.
02
Conditions
periodontitis
Beyond the preview
Go deeper on NCT04446533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04446533.